These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 38201233)

  • 1. Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy.
    Spano D; Catara G
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.
    Liu F; Chen J; Li K; Li H; Zhu Y; Zhai Y; Lu B; Fan Y; Liu Z; Chen X; Jia X; Dong Z; Liu K
    Mol Cancer; 2024 Jul; 23(1):148. PubMed ID: 39048965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
    Park J; Cho J; Song EJ
    Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases.
    Celebi G; Kesim H; Ozer E; Kutlu O
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the ubiquitin code in pancreatic cancer.
    Yang W; Wang S; Tong S; Zhang WD; Qin JJ
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166884. PubMed ID: 37704111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
    Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
    Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the ubiquitin proteasome system: beyond proteasome inhibition.
    Xolalpa W; Perez-Galan P; Rodríguez MS; Roué G
    Curr Pharm Des; 2013; 19(22):4053-93. PubMed ID: 23181575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination and E3 Ubiquitin Ligases in Rare Neurological Diseases with Comorbid Epilepsy.
    Zhu J; Tsai NP
    Neuroscience; 2020 Jan; 428():90-99. PubMed ID: 31931110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases.
    Stekel Z; Sheng Y; Zhang W
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome interaction with ubiquitinated substrates: from mechanisms to therapies.
    Chen X; Htet ZM; López-Alfonzo E; Martin A; Walters KJ
    FEBS J; 2021 Sep; 288(18):5231-5251. PubMed ID: 33211406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination: Friend and foe in cancer.
    Mansour MA
    Int J Biochem Cell Biol; 2018 Aug; 101():80-93. PubMed ID: 29864543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the Ubiquitin-Proteasome System: A Therapeutic Strategy for Autoimmune Diseases.
    Yadav D; Lee JY; Puranik N; Chauhan PS; Chavda V; Jin JO; Lee PCW
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.
    Landré V; Rotblat B; Melino S; Bernassola F; Melino G
    Oncotarget; 2014 Sep; 5(18):7988-8013. PubMed ID: 25237759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of ubiquitin ligases in cancer.
    Qi J; Ronai ZA
    Drug Resist Updat; 2015 Nov; 23():1-11. PubMed ID: 26690337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
    Kumar P; Kumar P; Mandal D; Velayutham R
    Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into a functional model of key deubiquitinases UBP12/13 in plants.
    Zhang S; Hu N; Yu F
    New Phytol; 2024 Apr; 242(2):424-430. PubMed ID: 38406992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.